Latin America In Vitro Diagnostics Market Size, Share & Trends Report Analysis By Product (Instruments, Reagents), By Technology (Immunoassay), By Application (Infectious Diseases), By End-use, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Product
                       1.1.2. Technology
                       1.1.3. Application
                       1.1.4. End use
                       1.1.5. Regional scope
                       1.1.6. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product outlook
                       2.2.2. Technology outlook
                       2.2.3. Application outlook
                       2.2.4. End use outlook
                       2.2.5. Regional outlook
                   2.3. Competitive Insights
Chapter 3. Latin America In Vitro Diagnostics Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Market Dynamics
                       3.3.1. Market driver analysis
                       3.3.2. Market restraint analysis
                   3.4. Latin America In Vitro Diagnostics Market Analysis Tools
                       3.4.1. Industry Analysis - Porter’s
                           3.4.1.1. Supplier power
                           3.4.1.2. Buyer power
                           3.4.1.3. Substitution threat
                           3.4.1.4. Threat of new entrant
                           3.4.1.5. Competitive rivalry
                       3.4.2. PESTEL Analysis
                           3.4.2.1. Political landscape
                           3.4.2.2. Technological landscape
                           3.4.2.3. Economic landscape
Chapter 4. Latin America In Vitro Diagnostics: Product Estimates & Trend Analysis
                   4.1. Latin America In Vitro Diagnostics Market: Key Takeaways
                   4.2. Latin America In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
                   4.3. Instruments
                       4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.4. Reagents
                       4.4.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.5. Software
                       4.5.1. Software market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Latin America In Vitro Diagnostics: Technology Estimates & Trend Analysis
                   5.1. Latin America In Vitro Diagnostics Market: Key Takeaways
                   5.2. Latin America In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
                   5.3. Immunoassay
                       5.3.1. Immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.4. Hematology
                       5.4.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.5. Clinical Chemistry
                       5.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.6. Molecular Diagnostics
                       5.6.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.7. Coagulation
                       5.7.1. Coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.8. Microbiology
                       5.8.1. Microbiology market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.9. Others
                       5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Latin America In Vitro Diagnostics: Application Estimates & Trend Analysis
                   6.1. Latin America In Vitro Diagnostics Market: Key Takeaways
                   6.2. Latin America In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
                   6.3. Infectious Disease
                       6.3.1. Infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.4. Diabetes
                       6.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.5. Oncology/Cancer
                       6.5.1. Oncology/cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.6. Cardiology
                       6.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.7. Nephrology
                       6.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.8. Autoimmune Diseases
                       6.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.9. Drug Testing
                       6.9.1. Drug testing market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.10. Others
                       6.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Latin America In Vitro Diagnostics: End Use Estimates & Trend Analysis
                   7.1. Latin America In Vitro Diagnostics Market: Key Takeaways
                   7.2. Latin America In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
                   7.3. Hospitals
                       7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
                   7.4. Laboratory
                       7.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
                   7.5. Home Care
                       7.5.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
                   7.6. Others
                       7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Latin America In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
                   8.1. Regional Outlook
                   8.2. Latin America In Vitro Diagnostics Market by Region: Key Takeaways
                   8.3. Latin America
                       8.3.1. Brazil
                           8.3.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.3.2. Mexico
                           8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.3.3. Argentina
                           8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
                   9.1. Recent Developments & Impact Analysis, By Key Market Participants
                   9.2. Market Participant Categorization
                       9.2.1. BD
                           9.2.1.1. Company overview
                           9.2.1.2. Financial performance
                           9.2.1.3. Product benchmarking
                           9.2.1.4. Strategic initiatives
                       9.2.2. BIOMÉRIEUX
                           9.2.2.1. Company overview
                           9.2.2.2. Financial performance
                           9.2.2.3. Product benchmarking
                           9.2.2.4. Strategic initiatives
                       9.2.3. Abbott.
                           9.2.3.1. Company overview
                           9.2.3.2. Financial performance
                           9.2.3.3. Product benchmarking
                           9.2.3.4. Strategic initiatives
                       9.2.4. Quidel Corporation.
                           9.2.4.1. Company overview
                           9.2.4.2. Financial performance
                           9.2.4.3. Product benchmarking
                           9.2.4.4. Strategic initiatives
                       9.2.5. OraSure Technologies
                           9.2.5.1. Company overview
                           9.2.5.2. Financial performance
                           9.2.5.3. Product benchmarking
                           9.2.5.4. Strategic initiatives
                       9.2.6. Hologic, Inc.
                           9.2.6.1. Company overview
                           9.2.6.2. Financial performance
                           9.2.6.3. Product benchmarking
                           9.2.6.4. Strategic initiatives
                       9.2.7. Cepheid.
                           9.2.7.1. Company overview
                           9.2.7.2. Financial performance
                           9.2.7.3. Product benchmarking
                           9.2.7.4. Strategic initiatives
                       9.2.8. QIAGEN
                           9.2.8.1. Company overview
                           9.2.8.2. Financial performance
                           9.2.8.3. Product benchmarking
                           9.2.8.4. Strategic initiatives
                       9.2.9. F. Hoffmann-La Roche Ltd.
                           9.2.9.1. Company overview
                           9.2.9.2. Financial performance
                           9.2.9.3. Product benchmarking
                           9.2.9.4. Strategic initiatives
                       9.2.10. Siemens Healthcare GmbH
                           9.2.10.1. Company overview
                           9.2.10.2. Financial performance
                           9.2.10.3. Product benchmarking
                           9.2.10.4. Strategic initiatives
                       9.2.11. Bio-Rad Laboratories, Inc.
                           9.2.11.1. Company overview
                           9.2.11.2. Financial performance
                           9.2.11.3. Product benchmarking
                           9.2.11.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 Latin America in vitro diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 Latin America in vitro diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 4 Latin America in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5 Latin America in vitro diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 6 Latin America in vitro diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 Brazil in vitro diagnostics market, by product, 2018 - 2030 (USD Million)
Table 8 Brazil in vitro diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 9 Brazil in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10 Brazil in vitro diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 Mexico in vitro diagnostics market, by product, 2018 - 2030 (USD Million)
Table 12 Mexico in vitro diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 13 Mexico in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
Table 14 Mexico in vitro diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 15 Argentina in vitro diagnostics market, by product, 2018 - 2030 (USD Million)
Table 16 Argentina in vitro diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 17 Argentina in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
Table 18 Argentina in vitro diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Latin America in vitro diagnostics: Market outlook
Fig. 9 Latin America in vitro diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Latin America in vitro diagnostics market driver impact
Fig. 15 Latin America in vitro diagnostics market restraint impact
Fig. 16 Latin America in vitro diagnostics market strategic initiatives analysis
Fig. 17 Latin America in vitro diagnostics market: Product movement analysis
Fig. 18 Latin America in vitro diagnostics market: Product outlook and key takeaways
Fig. 19 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Software market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Latin America in vitro diagnostics market: Technology movement analysis
Fig. 23 Latin America in vitro diagnostics market: Technology outlook and key takeaways
Fig. 24 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Coagulation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Microbiology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Latin America in vitro diagnostics market: Application movement analysis
Fig. 32 Latin America in vitro diagnostics market: Application outlook and key takeaways
Fig. 33 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Oncology/cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Nephrology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Drug testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Latin America in vitro diagnostics market: End use movement analysis
Fig. 42 Latin America in vitro diagnostics market: End use outlook and key takeaways
Fig. 43 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Laboratory market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Home care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Global Latin America in vitro diagnostics market: Regional movement analysis
Fig. 48 Global Latin America in vitro diagnostics market: Regional outlook and key takeaways
Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)